The Institutes for Pharmaceutical Discovery, L.L.C.

The Institutes for Pharmaceutical Discovery, L.L.C. (IPD), and its affiliate institutes, the Institute for Drug Discovery, L.L.C. (IDD), and Institute for Bioanalytics, L.L.C. (IBA), are privately held research companies founded in 1995 by James M. Nolan, President and CEO; Gordon Polley, Chairman; and Prof. Paul Zimmet, Director of International Research and Director Emeritus of the Baker-IDI Heart Institute.
Learn More

no description

- Contact Us
- The Institutes for
  Pharmaceutical Discovery, L.L.C.
  23 Business Park Drive
  Branford, CT 06405
  (203) 315-4000
  info@ipd-discovery.com
- Mission
- Our combination of industry-experienced scientists and management, IPD’s knowledge of the pharmaceutical industry, and its willingness and ability to work on novel targets make us the ideal partner to transform early, academically validated targets into valuable data packages with novel, patentable compounds as treatments for debilitating human diseases.
- Research
- IDD’s and IBA’s staff has experience with a variety of molecular targets, such as kinases, phosphatases,
  G-protein coupled receptors, various enzyme targets, and cellular transporters.
- What We Do
- IPD partners with scientists from major research institutions in the United States, Europe, and Australia to translate basic science discoveries into novel, patentable compounds and supporting data, or innovative diagnostic platforms.

Discovery is Our Mission